EPO906 Therapy in Patients With Prostate Cancer
Phase 2
Completed
- Conditions
- First Posted Date
- 2002-05-03
- Last Posted Date
- 2017-02-09
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 48
- Registration Number
- NCT00035113
- Locations
- ๐บ๐ธ
Pacific Shores Medical Group, Long Beach, California, United States
๐บ๐ธUniversity of Maryland - Greenbaum Cancer Center, Baltimore, Maryland, United States
๐บ๐ธCalifornia Pacific Medical Center, San Francisco, California, United States
EPO906 Therapy in Patients With Advanced Breast Cancer
- First Posted Date
- 2002-05-03
- Last Posted Date
- 2017-02-08
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 46
- Registration Number
- NCT00035126
- Locations
- ๐บ๐ธ
Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States
๐บ๐ธCancer Institute of New Jersey (CINJ), New Brunswick, New Jersey, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath